Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹4,571.20
1.00 (0.02%)
Medium VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹1.55L Cr
LARGE CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
72.4
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹3,140.1+45.6%
52W High₹4,712.9-3.0%
Current Price
₹4,571.20
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹3,656.96
Upper Circuit₹5,485.44
Reference Price
₹4,571.20
Investment Checklist
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹3885.9
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹3897.4
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Volume divergence: Bearish (price up, volume down)
Composite score 44.43 (BUY) with 53.9% confidence
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
54%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
4433.25
EMA50
4346.95
EMA200
3997.48
Price Action
UPTREND
BULLISH
Higher Highs7
Higher Lows6
Lower Highs2
Lower Lows3
Support & Resistance Levels
Resistance (Above)
₹4712.90
Support (Below)
₹4555.10
₹4478.60
₹4339.90
₹4246.43
₹4168.20
Volume Analysis
TrendDECREASING
Change-22.90%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Recent MA Crossovers
10/20 Bearish Cross
5 days ago
SELL
Stop Loss Levels
Fixed Risk
1% Risk₹4525.49
3% Risk₹4434.06
5% Risk₹4342.64
7% Risk (Custom)
₹4251.22Technical Levels
1x ATR (Volatility)₹4445.66
2x ATR (Swing)₹4320.12
3x ATR (Trend)₹4194.58
Immediate Support₹4555.10
Moving Averages
EMA 9 (Short-term)₹4477.35
EMA 20 (Medium-term)₹4433.25
EMA 50 (Trend)₹4346.95
EMA 200 (Long-term)₹3997.48
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹2,909.3 Cr | ₹3,128 Cr | ₹3,246 Cr | ₹3,251 Cr |
| Net Profit | ₹498.3 Cr | ₹548 Cr | ₹591 Cr | ₹635 Cr |
| EPS | — | ₹16.19 | ₹17.45 | ₹18.77 |
| Operating Profit | ₹921.1 Cr | ₹995 Cr | ₹1,043 Cr | ₹1,065 Cr |
ROE
25.18%
ROCE
27.09%
Debt/Equity
0.42
Current Ratio
1.19
OPM
32.76%
NPM
19.53%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
| BIOCON | Biocon Limited | ₹419.00 | +0.73% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 29 May 2026 | Dividend - Rs 9 Per Share | DIVIDEND |
| 18 Feb 2026 | Interim Dividend - Rs 29 Per Share | INTERIM_DIVIDEND |
| 20 Jun 2025 | Dividend - Rs 6 Per Share | DIVIDEND |
| 31 Jan 2025 | Interim Dividend - Rs 26 Per Sh | INTERIM_DIVIDEND |
| 21 Jun 2024 | Dividend - Rs 6 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for TORNTPHARM
View AllNEWS
positive
Business Standard - Markets 19d ago
Torrent Pharmaceuticals Ltd spurts 3.06%, rises for third straight session
Torrent Pharmaceuticals Ltd is quoting at Rs 4623.4, up 3.06% on the day as on 12:49 IST on the NSE. The stock is up 45.05% in last one year as compared to a 4.24% fall in NIFTY and a 14.46% fall in the Nifty Pharma index.
AONELIQUIDAONENIFTYAONETMMQ50AONETOTALBANKIETFPHARMABEESPVTBANIETFTORNTPHARMFinancial ServicesFINANCIAL SERVICES
NEWS
positive
Business Standard - Markets 21d ago
Torrent Pharmaceuticals consolidated net profit declines 26.91% in the March 2026 quarter
Sales rise 41.90% to Rs 4128.00 crore
TORNTPHARMHealthcare
positive
CNBC TV18 - Markets 21d ago
Torrent Pharma Q4 net profit tanks despite jump in revenue; declares ₹9 dividend
Shares of Torrent Pharmaceuticals Ltd ended at ₹4,494.00, up by ₹23.15, or 0.52%, on the BSE.
BSEDIVIDENDTORNTPHARMFinancial ServicesHealthcare